?

Biller Jonathan

EVP and Chief Legal Officer
Vertex Pharmaceuticals Incorporated
US, Boston [HQ]
CIK 1744749

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
16,863
Price per Share :
$418.27
Equivalence :
$7,053,287.01

Transaction History

  • A
    Form 4
    16,863 Shares After Transaction
    Value : $n/a
    $0.0
    02/06/24
  • Footnotes:
    #1 Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024.
    #2 Restricted stock unit award that vests in installments beginning on 02/17/2025.
  • A
    Form 4
    21,606 Shares After Transaction
    Value : $n/a
    $0.0
    02/07/24
  • F
    Form 4
    17,650 Shares After Transaction
    Value : $8,239,726.00
    $294,109.20
    10/01/24
  • S
    Form 4
    16,651 Shares After Transaction
    Value : $7,687,100.66
    Sold $461,198.34
    10/02/24
  • F
    Form 4
    20,018 Shares After Transaction
    Value : $8,462,409.32
    $671,311.12
    02/09/24

Get PRO Today.

PRO unlocks 1 more insider transactions made by Biller Jonathan

Start Free PRO trial Subscribe to PRO